Induction of natural killer-like cytotoxicity in cultured human thymocytes. 1983

M L Toribio, and M O De Landázuri, and M López-Botet

Supernatants containing interleukin 2 (IL 2) induce strong proliferation and expression of natural killer (NK)-like activity in human thymocytes. Different supernatants were compared for: (a) IL 2 activity, (b) thymocyte proliferation capacity and (c) induction of NK-like cytotoxicity. All these activities were present in a partially purified IL2 preparation obtained by gel filtration chromatography (Mr 15 000-20 000). However, in supernatants from different sources and in the 15 000-20 000-Mr semipurified fractions, we observed that the NK-like cytotoxicity inducer effect did not correlate with either the mitogenicity or the IL2 activity. The presence in the supernatants of interleukin 1 (IL 1), interferon (IFN) or phytohemagglutinin (PHA) does not seem to be a prerequisite for the induction of NK-like cytotoxicity, since this activity was (a) fully present in supernatants devoid of IL 1, IFN and PHA, (b) absent in preparations of IL 1 and (c) not augmented after supplementation of the supernatants with IFN-gamma. We also investigated the cellular characteristics of the precursor thymocytes responsive to IL 2 supernatants. Removal of the T3+ cells at the initiation of the culture abrogated the proliferative response and eliminated the generation of NK-like cytotoxicity. Under the same conditions, removal of the HTA1+ population increased the proliferation and did not affect the NK-like activity. Our results suggest that: (a) either IL 2 is not responsible for the induction of NK-like cytotoxicity or its action is modulated by other molecules, and (b) the precursor-responder population is preferentially included in the mature T3+ subset.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013950 Thymus Gland A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat. Thymus,Gland, Thymus,Glands, Thymus,Thymus Glands
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute

Related Publications

M L Toribio, and M O De Landázuri, and M López-Botet
January 1983, Natural immunity and cell growth regulation,
M L Toribio, and M O De Landázuri, and M López-Botet
March 1981, The Journal of pediatrics,
M L Toribio, and M O De Landázuri, and M López-Botet
December 1999, Experimental cell research,
M L Toribio, and M O De Landázuri, and M López-Botet
May 1982, Immunology letters,
M L Toribio, and M O De Landázuri, and M López-Botet
June 1981, Journal of immunology (Baltimore, Md. : 1950),
M L Toribio, and M O De Landázuri, and M López-Botet
January 1983, Scandinavian journal of immunology,
M L Toribio, and M O De Landázuri, and M López-Botet
July 1999, The Pediatric infectious disease journal,
M L Toribio, and M O De Landázuri, and M López-Botet
January 1998, Immunology,
M L Toribio, and M O De Landázuri, and M López-Botet
November 1982, Journal of immunology (Baltimore, Md. : 1950),
M L Toribio, and M O De Landázuri, and M López-Botet
November 1997, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!